Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer
CUPERTINO, Calif., Dec. 17, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in stage IIIb/IV non-small cell lung cancer (NSCLC). The...
LG Innotek Shines on Global Stage with Automotive Lighting Innovations
Front lighting module 'Nexlide A+' wins CES 2025 Innovation Award Industry's first application of surface light source technology to front lighting module, making it 40% slimmer and increasing brightness fivefold CEO Moon: "We will grow the...